News

Minor Residual Staining Found Adequate for Colonoscopy

Author and Disclosure Information

Key clinical point: Minor residual staining that does not obscure the bowel mucosa is adequate for detection of adenomas greater than 5 mm during surveillance or screening colonoscopy.

Major finding: Endoscopists missed about 5% of clinically significant adenomas, regardless of whether the Boston Bowel Preparation Score was 2 (minor residual staining) or 3 (entire mucosa seen well).

Data source: A blinded prospective observational study of 438 men at a single Veterans Affairs center.

Disclosures: The National Institutes of Health funded the study. The investigators had no disclosures.

View on the News

Study finding should encourage BBPS adoption

We have seen a dramatic increase in attention to improving the adenoma detection rate (ADR) during colonoscopy because patients of endoscopists with a higher ADR have a lower risk of colorectal cancer after colonoscopy. One major contributor to missed adenomas is inadequate bowel preparation, though little was known about how best to define adequacy.

Dr. Jason Domonitz

Clark and colleagues’ elegant tandem colonoscopy study helps address this knowledge gap using the Boston Bowel Preparation Scale (BBPS), a validated instrument that is easy to implement. They hypothesized that a BBPS colon-segment score of 2 was noninferior to a score of 3 for identifying adenomas greater than 5 mm, but that a BBPS colon-segment score of 1 would be inferior to scores of 2 or 3. Their findings support this hypothesis and give us long overdue data that we can now use to define an adequate bowel preparation. Given that the adenoma miss rate was 16% when the segment score was 1, but only about 5% with higher scores, it is reasonable to recommend repeat colonoscopy within 12 months if any segment score is less than 2. Otherwise, standard surveillance intervals should be recommended. Finally, unless and until other scoring systems are similarly validated, these findings should encourage the widespread adoption of the BBPS.

Dr. Jason A. Dominitz, AGAF, is the national program director for gastroenterology for the Veterans Health Administration and is professor of medicine in the division of gastroenterology at the University of Washington, Seattle. He has no conflicts of interest.


 

FROM GASTROENTEROLOGY

References

A Boston Bowel Preparation Scale (BBPS) score of 2 – indicating mild residual staining and small stool fragments – was as good as the optimal preparation score of 3 for visualizing polyps and adenomas larger than 5 mm and advanced adenomas during colonoscopy, researchers said.

A score of 2 might increase the chances of missing smaller polyps, but is adequate for detecting clinically significant masses, Dr. Brian Clark of Yale University, New Haven, Conn., and his associates reported in the February issue of Gastroenterology. But a score of 1 – meaning that there is enough staining or stool to obscure the mucosa – significantly increased the chances of missing adenomas larger than 5 mm, they said. Patients should undergo early repeat colonoscopy if their BBPS score is 1 or 0 in any colon segment, they emphasized.

Source: American Gastroenterological Association

Bowel preparation for colonoscopy is considered adequate if endoscopists can detect polyps larger than 5 mm, but no prior study had quantified the amount of preparation needed. This prospective observational study assessed adequate preparation in terms of the BBPS, which scores each of three colon segments on a scale of 0 (solid stool covering the mucosa) to 3 points (entire mucosa seen well, with no residual staining). Study participants included 438 men aged 50-75 years who underwent screening or surveillance colonoscopy at a single Veterans Affairs center, followed by repeat colonoscopies within 60 days performed by different blinded endoscopists. The investigators excluded patients who scored 0 in all colon segments or had familial polyposis syndrome, inflammatory bowel disease, polyps so large that they could not be completely removed, or a history of colonic or rectal resection. In all, they analyzed 1,161 colon segments (Gastroenterology. 2015 Dec 7. doi: 10.1053/j.gastro.2015.09.041).

Endoscopists missed about 5% of adenomas greater than 5 mm, regardless of whether BBPS scores were 2 or 3 in a model that accounted for age, reason for colonoscopy, colon segment, number of polyps removed in the first examination, and endoscopist performing the procedure, the researchers said. But when BBPS scores were 1, endoscopists missed 16% of adenomas larger than 5 mm, a difference of about 10%. Furthermore, 43% of screening and surveillance intervals would have been incorrect had they been based solely on an initial examination for which scores were 1 in at least one segment. In contrast, only about 15% of intervals would have been incorrect for patients who scored 2 or 3 in all segments.

In all, 80% of patients were sufficiently prepared, having scored at least 2 in all segments on the first examination. “Determining whether a patient’s preparation quality is adequate is one of the most common and important decisions made by gastroenterologists each day,” the researchers said. Between 25% and 30% of screening and surveillance colonoscopies occur at “inappropriately shortened intervals,” often because of uncertainty about what constitutes adequate visualization, they added. Defining adequate visualization based on bowel preparation could save billions of dollars in health care costs every year, minimize complications from unnecessary procedures, and pinpoint those patients who truly need an early repeat colonoscopy to help prevent interval colorectal cancer, they emphasized.

The National Institutes of Health funded the study. The investigators had no disclosures.

Recommended Reading

C difficile Risk Score Identifies High-risk Patients
Clinician Reviews
Gut Microbiota May Predict C diff Treatment Response
Clinician Reviews
Legionellosis Cases Continue to Increase Nationwide
Clinician Reviews
Study Eyes Gut Microbiota Changes in Diabetic Kidney Disease
Clinician Reviews
Shingles Vaccine Protection Lasted 5-6 Years in Autoimmune Disease Patients
Clinician Reviews
Partnering With Patients to Optimize Diabetes Therapy
Clinician Reviews
Gut Grief: The Truth About Gluten Sensitivity
Clinician Reviews
Updates in Pediatrics
Clinician Reviews
Proton Pump Inhibitors Linked to Chronic Kidney Disease
Clinician Reviews
Moderate, Intensive Exercise Cut Triglycerides Equally in NAFLD
Clinician Reviews